Rational discovery of therapeutic PAK1 allosteric activators
Cell · 2026-05 · 189 (11) · 3444-3464.e28
DOI: 10.1016/j.cell.2026.03.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-05. Verfasst von Yu He und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK. Hauptthemen laut MEDLINE: p21-Activated Kinases, Enzyme Activators. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council, University of Oxford BHF Centre of Research Excellence, British Heart Foundation.
Abstract (Originalsprache)
Although kinase activators hold significant therapeutic promise, their development remains challenging and rarely achieved. Here, we report the discovery of direct small-molecule activators of p21-activated kinase-1 (PAK1), a key regulator of cardiac homeostasis, using a rational peptide-guided strategy. Targeting PAK1 autoinhibitory regulation, we identified a previously unrecognized autoinhibition-release site between the autoregulatory region and the kinase domain. Subsequent high-throughput screening and medicinal chemistry optimization yielded selective allosteric activators that enhance PAK1 activity with micromolar potency and isoform selectivity. Structural and mechanistic analyses indicate that these activators disrupt autoinhibitory regulation and promote local and global conformational transitions to the active state. Enhanced PAK1 signaling was confirmed in cardiac cells, and in vivo studies demonstrated therapeutic efficacy in both inherited and acquired cardiac hypertrophy. Collectively, these findings establish rational modulation of kinase autoinhibitory regulation as a potential strategy for the broader discovery of kinase activators, a largely unexplored area of therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
- Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK. Electronic address: shb45@cam.ac.uk.
- Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, Trojdena 4, 02-109 Warsaw, Poland; Preclinical Drug Development Facility at IN-MOL-CELL, International Institute of Molecular and C…
- Department of Statistics, University of Oxford, Oxford OX1 3PB, UK.
- Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK.
- Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.
Förderung
- UK Research and Innovation Medical Research Council
- University of Oxford BHF Centre of Research Excellence
- British Heart Foundation
- National Natural Science Foundation of China
- Engineering and Physical Sciences Research Council
- National Science Centre Poland
Zitieren
APA
He, Y., Bae, J. S. H., Nowak, E., Outeiral, C., Nissley, D. A., Tumber, A., Berridge, G., Salah, E., Wang, Y., He, W., Zhang, H., Chen, T., Tusk, S., Mathea, S., Wang, Y. J., Grassam-Rowe, A., Kukura, P., Schofield, C. J., O'Brien, D. P., …, & Lei, M. (2026). Rational discovery of therapeutic PAK1 allosteric activators. Cell, 189(11), 3444-3464.e28. https://doi.org/10.1016/j.cell.2026.03.008
Vancouver
He Y, Bae JSH, Nowak E, Outeiral C, Nissley DA, Tumber A, et al. Rational discovery of therapeutic PAK1 allosteric activators. Cell. 2026;189(11):3444-3464.e28. doi:10.1016/j.cell.2026.03.008
BibTeX
@article{He2026,
author = {He, Yu and Bae, James S H and Nowak, Elżbieta and Outeiral, Carlos and Nissley, Daniel A and Tumber, Anthony and Berridge, Georgina and Salah, Eidarus and Wang, Yi and He, Wenqi and Zhang, Hongyuan and Chen, Tangting and Tusk, Samuel and Mathea, Sebastian and Wang, Ying-Jie and Grassam-Rowe, Alexander and Kukura, Philipp and Schofield, Christopher J and O'Brien, Darragh P and Pierangelini, Andrea and Churchill, Grant C and Lanyon-Hogg, Thomas and Ke, Yunbo and Xu, Chao and Ye, Tao and Watkins, Hugh and Ying, Liming and Koschinski, Andreas and Solaro, R John and Tan, Xiaoqiu and Bolla, Jani R and Wang, Xin and Knapp, Stefan and Deane, Charlotte M and Zaccolo, Manuela and Nowotny, Marcin and Lei, Ming},
title = {Rational discovery of therapeutic PAK1 allosteric activators},
journal = {Cell},
year = {2026},
volume = {189},
number = {11},
pages = {3444--3464.e28},
doi = {10.1016/j.cell.2026.03.008}
}
EUVIMED